Genotyping of Pseudomonas aeruginosa reveals high diversity, stability over time and good outcome of eradication

Journal of Cystic Fibrosis

Volumn 14, Issue 3, 2015, Pages 353-360

  Johansson, E ^a,b   Welinder Olsson, C ^a,b   Gilljam, M ^a,c,e   Pourcel, C ^g   Lindblad, A ^c,d,f  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Gothenburg CF Centre   (Sweden)

^d QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^g UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Epidemiological surveillance; Genotyping; MLVA; PFGE; Pseudomonas aeruginosa

Indexed keywords

ARTICLE; BACTERIAL CLEARANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE SURVEILLANCE; ERADICATION THERAPY; FEMALE; GENOTYPING TECHNIQUE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MULTIPLE LOCUS VARIABLE NUMBER OF TANDEM REPEAT ANALYSIS; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SPECIES DIFFERENCE; VARIABLE NUMBER OF TANDEM REPEAT; ADOLESCENT; ADULT; BACTERIUM IDENTIFICATION; COMPLICATION; CYSTIC FIBROSIS; GENETICS; GENOTYPE; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDY; SWEDEN; YOUNG ADULT;

BACTERIAL DNA;

ADOLESCENT; ADULT; BACTERIAL TYPING TECHNIQUES; CYSTIC FIBROSIS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SWEDEN; YOUNG ADULT;

EID: 84937407144     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.09.016     Document Type: Article

References (27)

1. Cystic Fibrosis Foundation Patient Registry 2005 Annual Report 2006, Cystic Fibrosis Foundation, Bethesda, Maryland.
2. Lee T., Brownlee K., Conway S., Denton M., Littlewood J. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2:29-34.
3. Cheng K., Smyth R.L., Govan J.R., Doherty C., Winstanley C., Denning N., et al. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996, 348:639-642.
4. Jones A.M., Govan J.R., Doherty C.J., Dodd M.E., Isalska B.J., Stanbridge T.N., et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult fibrosis clinic. Lancet 2001, 358:557-558.
5. Armstrong D.S., Nixon G.M., Carzino R., Bigham A., Carlin J.B., Robins-Browne R.M., et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002, 166:983-987.
6. Scott F.W., Pitt T.L. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 2004, 53:609-615.
7. Römling U., Kader A., Sriramulu D.D., Simm R., Kronvall G. Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients. Environ Microbiol 2005, 7:1029-1038.
8. Kidd T., Ramsay K.A., Hu H., Marks G.B., Wainwright C.E., Bye P.T., et al. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J 2013, 41:1091-1100.
9. Ojeniyi B., Frederiksen B., Hoiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. J Clin Microbiol 1995, 33:177-181.
10. Brimicombe R.W., T.J.van det Reijden, Kardoes I., Pitt T.L., van den Broek P.J., et al. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 2008, 7:30-36.
11. Meyer P., Johansson E., Welinder-Olsson C., Lindblad A., Hjelte L., Karpati F. Pseudomonas aeruginosa transmission at a winter camp in spite of rigorous precautions. J Cyst Fibros 2007, 6:S28:114.
12. Waine D., Whitehouse J., Honeybourne D. Cross-infection in cystic fibrosis: the knowledge and behaviour of adult patients. J Cyst Fibros 2007, 6:262-266.
13. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
14. Onteniente L., Brisse S., Tassios P.T., Vergnaud G. Evaluation of the polymorphisms associated with tandem repeats for Pseudomonas aeruginosa strain typing. J Clin Microbiol 2003, 41:4991-4997.
15. Vu-Thien H., Corbineau G., Hormigos K., Fauroux B., Corvol H., Clément A., et al. Multiple-locus variable-number tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients. J Clin Microbiol 2007, 45:3175-3183.
16. Turton J.F., Turton S.E., Yearwood L., Yarde S., Kaufmann M.E., Pitt T.L. Evaluation of a nine-locus variable-number tandem-repeat scheme for typing of Pseudomonas aeruginosa. Clin Microbiol Infect 2010 Aug, 16(8):1111-1116.
17. Van der Bij A.K., Van Mansfeld R., Peirano G., Goessens W.H.F., Severin J.A., Pitout J.D.D., et al. First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes. Int J Antimicrob Agents 2011, 37:513-518.
18. Sobral D., Mariani-Kurkdjian P., Bingen E., Vu-Thien H., Hormigos K., Lebeau B., et al. A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 2012, 31:2247-2256.
19. Johansson E., Welinder-Olsson C., Gilljam M. Genotyping of Pseudomonas aeruginosa isolates from lung transplant recipients and aquatic environment detected in-hospital transmission. APMIS 2013, 122:85-91.
20. Döring G., Hoiby N. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004, 3(2):67-91.
21. Vosahlikova S., Drevinek P., Cinek O., Pohunek P., Maixnerova M., Urbaskova P., et al. High genotypic diversity of Pseudomonas aeruginosa stains isolated from patients with cystic fibrosis in the Czech Republic. Res Microbiol 2007, 158:324-329.
22. Schmid J., Ling L., Leung J., Zhang N., Kolbe J., Wesley A., et al. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics. Eur Respir J 2008, 32:1583-1590.
23. Al-Aloul M., Crawley J., Winstanley C., Hart C.A., Ledson M.J., Walshaw M.J. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004, 594:334-336.
24. Jones A.M., Dodd M.E., Morris J., Doherty C., Govan R.W., Webb A.K. Outcome for cystic fibrosis patients infected with transmissible clinical Pseudomonas aeruginosa: an 8-year prospective study. Chest 2010, 137(6):1405-1409.
25. Tingpej P., Elkins M., Rose B., Hu H., Moriarty C., Manos J., et al. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa. Respirology 2010, 15:923-929.
26. Jelsbak L., Johansen H.K., Frost A.L., Thøgersen R., Thomsen L.E., Ciofu O., et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 2007, 75(5):2214-2224.
27. Ashish A., Shaw M., Winstanley C., Humphreys L., Walshaw M.J. Halting the spread of epidemic Pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study. JRSM Short Rep 2013, 4(1):1.